DBV Technologies SA (DBVT)
0.475
-0.01
(-2.68%)
USD |
NASDAQ |
Nov 22, 11:37
DBV Technologies Total Assets (Quarterly): 93.06M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 93.06M |
| June 30, 2024 | 114.19M |
| March 31, 2024 | 145.90M |
| December 31, 2023 | 182.99M |
| September 30, 2023 | 189.78M |
| June 30, 2023 | 217.52M |
| March 31, 2023 | 232.93M |
| December 31, 2022 | 246.52M |
| September 30, 2022 | 248.12M |
| June 30, 2022 | 284.98M |
| March 31, 2022 | 117.58M |
| December 31, 2021 | 146.72M |
| September 30, 2021 | 170.92M |
| June 30, 2021 | 200.58M |
| March 31, 2021 | 221.40M |
| December 31, 2020 | 272.25M |
| June 30, 2020 | 337.01M |
| December 31, 2019 | 271.72M |
| September 30, 2019 | 168.81M |
| June 30, 2019 | 212.23M |
| June 30, 2019 | 212.23M |
| Date | Value |
|---|---|
| December 31, 2018 | 196.46M |
| June 30, 2018 | 289.36M |
| June 30, 2018 | 289.36M |
| December 31, 2017 | 213.32M |
| June 30, 2017 | 272.16M |
| June 30, 2017 | 272.16M |
| December 31, 2016 | 302.36M |
| June 30, 2016 | 364.91M |
| June 30, 2016 | 364.91M |
| December 31, 2015 | 375.31M |
| June 30, 2015 | 133.48M |
| June 30, 2015 | 133.48M |
| December 31, 2014 | 152.51M |
| June 30, 2014 | 52.94M |
| June 30, 2014 | 52.94M |
| December 31, 2013 | 63.85M |
| June 30, 2013 | 50.45M |
| June 30, 2013 | 50.45M |
| December 31, 2012 | 56.83M |
| June 30, 2012 | 60.04M |
| December 31, 2011 | 20.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
93.06M
Minimum
Sep 2024
337.01M
Maximum
Jun 2020
205.23M
Average
209.05M
Median
Total Assets (Quarterly) Benchmarks
| Edap TMS SA | 88.28M |
| Cellectis SA | 395.88M |
| Genfit SA | 192.20M |
| Adaptimmune Therapeutics PLC | 317.44M |
| Akari Therapeutics PLC | 2.734M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.02M |
| Shareholders Equity (Quarterly) | 54.03M |